J.P. Morgan Private Wealth Advisors LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$226,000
-29.6%
2,247
-0.9%
0.00%0.0%
Q2 2021$321,000
+35.4%
2,268
-4.5%
0.00%0.0%
Q1 2021$237,000
-20.7%
2,375
-1.8%
0.00%0.0%
Q4 2020$299,000
-13.6%
2,418
-31.9%
0.00%0.0%
Q3 2020$346,000
-24.5%
3,552
+21.1%
0.00%
-50.0%
Q2 2020$458,000
+44.9%
2,934
+34.2%
0.00%0.0%
Q1 2020$316,000
-16.4%
2,187
+18.3%
0.00%0.0%
Q4 2019$378,0001,8490.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders